RedHill’s oral broad-acting antiviral, Opaganib, granted new COVID-19 treatment patent
TEL AVIV, Israel and RALEIGH, NC, October 19, 2022, RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty ...
Tag: RedHills
-
New study shows snacking on mixed tree nuts may impact cardiovascular risk factors and increase serotonin
-
Ignoring Native American data perpetuates misleading white ‘deaths of despair’ narrative, study finds
-
Mount Sinai researchers awarded $12 million NIH grant to create a center to unravel novel causes of food allergy and atopic dermatitis
-
Hydrogen peroxide from tea and coffee residue: New pathway to sustainability
-
Volcano-like rupture could have caused magnetar slowdown
-
The next generation of global health innovators: Michelson Prize winners announced